Xlear: Difference between revisions
Added infobox |
Change infobox template |
||
| Line 1: | Line 1: | ||
{{Stub}} | {{Stub}} | ||
{{ | {{CompanyInfobox | ||
|Company=Xlear | |Company=Xlear | ||
|Founded=2000 | |Founded=2000 | ||
Revision as of 12:20, 14 August 2025
❗This article is a stub. You can help by expanding it.
A moderator needs to check the page before this notice can be removed. Visit the noticeboard or the
#appeals channel in either Zulip or Discord to request removal.More info ▼
An article may be flagged as a stub when it is missing major elements needed to make it useful to a reader. You can help by adding missing sections, verifiable sources, relevant company policies and communications, etc. to make the article more complete.
Xlear is a Utah-based nasal spray company which falsely advertised its nasal spray as a COVID-19 preventative and treatment. In 2021, the FTC sued Xlear for this false claim.[1][2]
References
- ↑ Felner, Lauren (2025-06-25). "A nasal spray company wants to make it harder for the FTS to police health claims". The Verge.
- ↑ "FTC Sues Utah-based Company for Falsely Claiming Its Nasal Sprays Can Prevent and Treat COVID-19". Federal Trade Commission. 2021-10-28.